Advanced vs Standard Hemodynamic Monitoring During Propofol Sedation for ERCP: A Prospective Study
Comparison of Advanced Hemodynamic Monitoring With Standard Monitoring During Propofol Sedation in ERCP Procedures: A Prospective Observational Study
1 other identifier
observational
32
1 country
1
Brief Summary
The aim of this study is to evaluate whether there is a difference in hemodynamic events requiring intervention between patients monitored with advanced hemodynamic monitoring using the MostCare system and those monitored with standard monitoring alone during propofol sedation for ERCP procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2026
CompletedFirst Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
ExpectedApril 23, 2026
April 1, 2026
29 days
April 13, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of hemodynamic events requiring clinical intervention during ERCP under propofol sedation
Hemodynamic events requiring intervention, including hypotension (MAP \<65 mmHg), bradycardia (HR \<50 bpm), hypoxemia (SpO₂ \<92%), or sedation-depth abnormalities requiring treatment adjustment, will be recorded and compared between groups
From the start of sedation until the end of the ERCP procedure
Study Arms (2)
Group 1 - Standard Monitoring Group
In this group, sedation depth will be monitored using non-invasive arterial blood pressure (NIBP), electrocardiography (ECG), pulse oximetry (SpO₂), and BIS. Arterial cannulation and advanced hemodynamic monitoring will not be applied.
Group 2 - Advanced Hemodynamic Monitoring Group
In addition to standard monitoring parameters, radial arterial cannulation will be performed, and advanced hemodynamic variables including cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume index (SVI), systemic vascular resistance and systemic vascular resistance index (SVR), arterial elastance (Ea), cardiac cycle efficiency (CCE), and cardiac power output (CPO) will be monitored using the MostCare system (Vygon, Italy).
Interventions
Advanced hemodynamic monitoring performed using the MostCare system via radial arterial cannulation during ERCP under propofol sedation.
Standard intra-procedural monitoring including non-invasive blood pressure, ECG, pulse oximetry, and BIS during ERCP under propofol sedation
Eligibility Criteria
The study population consists of adult patients with ASA physical status III or higher who are scheduled for elective ERCP and managed under propofol sedation while maintaining spontaneous respiration in a single-center tertiary care university hospital setting.
You may qualify if:
- Adults aged 18 years and older
- Patients with an ASA physical status score of III or higher scheduled for ERCP
- Patients maintaining spontaneous respiration
- Patients who have provided written informed consent
You may not qualify if:
- Patients requiring general anesthesia
- Patients requiring mechanical ventilation
- Patients unsuitable for arterial catheterization due to coagulopathy or local infection
- Pregnant women
- Patients who do not sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
Study Sites (1)
Hitit university
Çorum, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ozgur Yagan, Professor
Hitit University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 20, 2026
Study Start
March 27, 2026
Primary Completion
April 25, 2026
Study Completion (Estimated)
May 15, 2026
Last Updated
April 23, 2026
Record last verified: 2026-04